From Name:
From Email:
To Name:
To Email:

Optional Message:

Shutdown looming, FDA approves new depression drug from Lundbeck, Takeda

from FierceBiotech

Regulators at the FDA stamped an approval on Brintellix, a new therapy to treat major depression from Lundbeck and Takeda, just hours before the government prepared to hunker down in a partial shutdown. Investigators sent their application in with a battery of late-stage results for Brintellix. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063